id	domain	url
biomedich-607	doi.org	https://doi.org/10.14421/biomedich.2024.132.559-564
biomedich-607	doi.org	https://doi.org/10.3389/fcvm.2022.933215
biomedich-607	doi.org	https://doi.org/10.1016/j.jceh.2014.06.004
biomedich-607	dx.doi.org	http://dx.doi.org/10.1016/j.tips.2014.03.001
biomedich-607	doi.org	https://doi.org/10.1038/s41574-021-00606-x
biomedich-607	doi.org	https://doi.org/10.3389/fcvm.2022.933215
biomedich-607	doi.org	https://doi.org/10.1016/j.jceh.2014.06.004
biomedich-607	dx.doi.org	http://dx.doi.org/10.1016/j.tips.2014.03.001
biomedich-607	doi.org	https://doi.org/10.1038/s41574-021-00606-x
biomedich-607	doi.org	https://doi.org/10.4088/jcp.16f10721
biomedich-607	doi.org	https://doi.org/10.1039/c7tx00340d
biomedich-607	doi.org	https://doi.org/10.1016/j.yhbeh.2018.01.003
biomedich-607	doi.org	https://doi.org/10.1038/s41574-021-00553-7
biomedich-607	doi.org	https://doi.org/10.1111/head.12550
biomedich-607	doi.org	https://doi.org/10.1016/j.ydbio.2005.10.013
biomedich-607	doi.org	https://doi.org/10.1002/jat.3586
biomedich-607	doi.org	https://doi.org/10.1038/s41574-02100605-y
biomedich-607	doi.org	https://doi.org/10.1038/nchembio.663
biomedich-607	www.ema.europa.eu	https://www.ema.europa.eu/en/human-regulatoryoverview/post-authorisation/pharmacovigilance-postauthorisation/signal-management/prac-recommendationssafety-signals
biomedich-607	www.fda.gov	https://www.fda.gov/drugs/drug-safety-and-availability/fdadrug-safety-communication-fda-has-reviewed-possible-riskspain-medicine-use-during-pregnancy
biomedich-607	doi.org	https://doi.org/10.1163/156856003322699573
biomedich-607	doi.org	https://doi.org/10.1007/s10787-013-0172-x
biomedich-607	doi.org	https://doi.org/10.1016/j.scitotenv.2020.144585
biomedich-607	doi.org	https://doi.org/10.1016/j.pain.2006.10.020
biomedich-607	doi.org	https://doi.org/10.1136/bmjopen-2013-004365
biomedich-607	doi.org	https://doi.org/10.1111/bcp.13656
biomedich-607	doi.org	https://doi.org/10.1136/ejhpharm-2016000952
biomedich-607	doi.org	https://doi.org/10.1080/14767058.2021.2005020
biomedich-607	doi.org	https://doi.org/10.1111/aogs.14557
biomedich-607	doi.org	https://doi.org/10.1002/14651858.cd010061.pub4
biomedich-607	doi.org	https://doi.org/10.1002/dvdy.24495
biomedich-607	doi.org	https://doi.org/10.1007/s10194-008-0071-5
biomedich-607	doi.org	https://doi.org/10.4088/jcp.16f10721
biomedich-607	doi.org	https://doi.org/10.1039/c7tx00340d
biomedich-607	doi.org	https://doi.org/10.1016/j.yhbeh.2018.01.003
biomedich-607	doi.org	https://doi.org/10.1038/s41574-021-00553-7
biomedich-607	doi.org	https://doi.org/10.1111/head.12550
biomedich-607	doi.org	https://doi.org/10.1016/j.ydbio.2005.10.013
biomedich-607	doi.org	https://doi.org/10.1016/j.ydbio.2005.10.013
biomedich-607	doi.org	https://doi.org/10.1016/j.ydbio.2005.10.013
biomedich-607	doi.org	https://doi.org/10.1002/jat.3586
biomedich-607	doi.org	https://doi.org/10.1038/s41574-021-00605-y
biomedich-607	doi.org	https://doi.org/10.1038/s41574-021-00605-y
biomedich-607	doi.org	https://doi.org/10.1038/nchembio.663
biomedich-607	www.ema.europa.eu	https://www.ema.europa.eu/en/human-regulatory-overview/post-authorisation/pharmacovigilance-post-authorisation/signal-management/prac-recommendations-safety-signals
biomedich-607	www.ema.europa.eu	https://www.ema.europa.eu/en/human-regulatory-overview/post-authorisation/pharmacovigilance-post-authorisation/signal-management/prac-recommendations-safety-signals
biomedich-607	www.ema.europa.eu	https://www.ema.europa.eu/en/human-regulatory-overview/post-authorisation/pharmacovigilance-post-authorisation/signal-management/prac-recommendations-safety-signals
biomedich-607	www.ema.europa.eu	https://www.ema.europa.eu/en/human-regulatory-overview/post-authorisation/pharmacovigilance-post-authorisation/signal-management/prac-recommendations-safety-signals
biomedich-607	www.fda.gov	https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-fda-has-reviewed-possible-risks-pain-medicine-use-during-pregnancy
biomedich-607	www.fda.gov	https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-fda-has-reviewed-possible-risks-pain-medicine-use-during-pregnancy
biomedich-607	www.fda.gov	https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-fda-has-reviewed-possible-risks-pain-medicine-use-during-pregnancy
biomedich-607	doi.org	https://doi.org/10.1163/156856003322699573
biomedich-607	doi.org	https://doi.org/10.1007/s10787-013-0172-x
biomedich-607	doi.org	https://doi.org/10.1016/j.scitotenv.2020.144585
biomedich-607	doi.org	https://doi.org/10.1016/j.scitotenv.2020.144585
biomedich-607	doi.org	https://doi.org/10.1016/j.scitotenv.2020.144585
biomedich-607	doi.org	https://doi.org/10.1016/j.pain.2006.10.020
biomedich-607	doi.org	https://doi.org/10.1136/bmjopen-2013-004365
biomedich-607	doi.org	https://doi.org/10.1111/bcp.13656
biomedich-607	doi.org	https://doi.org/10.1136/ejhpharm-2016-000952
biomedich-607	doi.org	https://doi.org/10.1136/ejhpharm-2016-000952
biomedich-607	doi.org	https://doi.org/10.1080/14767058.2021.2005020
biomedich-607	doi.org	https://doi.org/10.1111/aogs.14557
biomedich-607	doi.org	https://doi.org/10.1002/14651858.cd010061.pub4
biomedich-607	doi.org	https://doi.org/10.1002/dvdy.24495
biomedich-607	doi.org	https://doi.org/10.1007/s10194-008-0071-5
biomedich-607	doi.org	https://doi.org/10.1089/vim.2009.004
biomedich-607	doi.org	https://doi.org/10.1016/0002-9378(86)90173-0
biomedich-607	doi.org	https://doi.org/10.1016/j.prp.2023.154478
biomedich-607	doi.org	https://doi.org/10.1016/j.scitotenv.2021.150541
biomedich-607	doi.org	https://doi.org/10.1007/s11095-0120964-5
biomedich-607	doi.org	https://doi.org/10.3748/wjg.v19.i48.9240
biomedich-607	doi.org	https://doi.org/10.3945/ajcn.110.003483
biomedich-607	dx.doi.org	http://dx.doi.org/10.1016/j.plipres.2017.04.003
biomedich-607	doi.org	https://doi.org/10.1007/s11011-020-00549-8
biomedich-607	doi.org	https://doi.org/10.1093/bjaceaccp/mkt049
biomedich-607	doi.org	https://doi.org/10.3109/00498254.2016.1166533
biomedich-607	doi.org	https://doi.org/10.1161/hypertensionaha.121.17713
biomedich-607	doi.org	https://doi.org/10.1016/j.ajog.2005.02.100
biomedich-607	doi.org	https://doi.org/10.1016/j.chemosphere.2017.05.054
biomedich-607	doi.org	https://doi.org/10.1038/s41598-020-71237-x
biomedich-607	doi.org	https://doi.org/10.1089/vim.2009.004
biomedich-607	doi.org	https://doi.org/10.1016/0002-9378(86)90173-0
biomedich-607	doi.org	https://doi.org/10.1016/j.prp.2023.154478
biomedich-607	doi.org	https://doi.org/10.1016/j.scitotenv.2021.150541
biomedich-607	doi.org	https://doi.org/10.1016/j.scitotenv.2021.150541
biomedich-607	doi.org	https://doi.org/10.1016/j.scitotenv.2021.150541
biomedich-607	doi.org	https://doi.org/10.1007/s11095-012-0964-5
biomedich-607	doi.org	https://doi.org/10.1007/s11095-012-0964-5
biomedich-607	doi.org	https://doi.org/10.1016/j.cub.2014.03.034
biomedich-607	doi.org	https://doi.org/10.1016/j.cub.2014.03.034
biomedich-607	doi.org	https://doi.org/10.3748/wjg.v19.i48.9240
biomedich-607	doi.org	https://doi.org/10.3945/ajcn.110.003483
biomedich-607	dx.doi.org	http://dx.doi.org/10.1016/j.plipres.2017.04.003
biomedich-607	doi.org	https://doi.org/10.1007/s11011-020-00549-8
biomedich-607	doi.org	https://doi.org/10.1093/bjaceaccp/mkt049
biomedich-607	doi.org	https://doi.org/10.3109/00498254.2016.1166533
biomedich-607	doi.org	https://doi.org/10.1161/hypertensionaha.121.17713
biomedich-607	doi.org	https://doi.org/10.1016/j.ajog.2005.02.100
biomedich-607	doi.org	https://doi.org/10.1016/j.chemosphere.2017.05.054
biomedich-607	doi.org	https://doi.org/10.1038/s41598-020-71237-x